Mammalian orthoreoviruses (reoviruses) are highly tractable experimental models for studies of double-stranded (ds) RNA virus replication and pathogenesis. Reoviruses infect respiratory and intestinal epithelium and disseminate systemically in newborn animals. Until now, a strategy to rescue infectious virus from cloned cDNA has not been available for any member of the Reoviridae family of dsRNA viruses. We report the generation of viable reovirus following plasmid transfection of murine L929 (L) cells using a strategy free of helper virus and independent of selection. We used the reovirus reverse genetics system to introduce mutations into viral capsid proteins sigma1 and sigma3 and to rescue a virus that expresses a green fluorescent protein (GFP) transgene, thus demonstrating the tractability of this technology. The plasmid-based reverse genetics approach described here can be exploited for studies of reovirus replication and pathogenesis and used to develop reovirus as a vaccine vector.

During viral infection, cells initiate antiviral responses to contain replication and inhibit virus spread. One protective mechanism involves activation of transcription factors interferon regulatory factor-3 (IRF-3) and NF-B, resulting in secretion of the antiviral cytokine, interferon-␤. Another is induction of apoptosis, killing the host cell before virus disseminates. Mammalian reovirus induces both interferon-␤ and apoptosis, raising the possibility that both pathways are initiated by a common cellular sensor. We show here that reovirus activates IRF-3 with kinetics that parallel the activation of NF-B, a known mediator of reovirus-induced apoptosis. Activation of IRF-3 requires functional retinoic acid inducible gene-I and interferon-␤ promoter stimulator-1, but these intracellular sensors are dispensable for activation of NF-B. Interferon-␤ promoter stimulator-1 and IRF-3 are required for efficient apoptosis following reovirus infection, suggesting a common mechanism of antiviral cytokine induction and activation of the cell death response.A primary function of the innate immune system is to detect nascent viral infections and direct subsequent cellular responses. The innate immune system responds to infection by producing a range of soluble cytokines, such as interferon-␤ (IFN-␤), 5 that create an antiviral state in surrounding tissue. In response to these immune pressures, viruses have evolved multiple strategies for subverting innate immunity, which frequently center on manipulating cell death pathways. The interface between the innate immune response, viral infection, and the cellular apoptotic machinery is therefore a critical nexus of disease pathogenesis.Cells possess a variety of sensors to detect invading pathogens. Toll-like receptors (TLRs) and other pattern recognition receptors, including the nucleotide-binding oligomerization domain proteins and RNA helicases such as retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated protein-5 (Mda-5), recognize viral pathogen-associated molecular patterns (1). TLRs are expressed on the cell surface and recognize extracellular pathogen-associated molecular patterns, whereas RIG-I and Mda-5 detect intracellular viral RNA products (2-4). RIG-I recognizes viral RNAs from the Flaviviridae, Orthomyxoviridae, Paramyxoviridae, and Rhabdoviridae families, whereas Mda-5 is involved in the response to Picornaviridae (4). The ligand for RIG-I has been identified as a 5Ј triphosphate moiety on single-or double-stranded RNA (5, 6); the molecular ligand for Mda-5 is unknown. Following ligand engagement, these intracellular sensors signal through caspase activation and recruitment domains to activate the adaptor, interferon-␤ promoter stimulator-1 (IPS-1/MAVS/ VISA/Cardif) (7-10). IPS-1 activates inhibitor of B kinase (IKK)-␣, IKK-␤, IKK-⑀, and Tank-binding kinase 1 to phosphorylate transcription factors, including activating transcription factor-2/c-Jun, NF-B, and interferon regulatory factor-3 (IRF-3), which direct transcription of antiviral g...

During entry into host cells, poliovirus undergoes a receptor-mediated conformational transition to form 135S particles with irreversible exposure of VP4 capsid sequences and VP1 N termini. To understand the role of VP4 during virus entry, the fate of VP4 during infection by site-specific mutants at threonine-28 of VP4 (4028T) was compared with that of the parental Mahoney type 1 virus. Three virus mutants were studied: the entry-defective, nonviable mutant 4028T.G and the viable mutants 4028T.S and 4028T.V, in which residue threonine-28 was changed to glycine, serine, and valine, respectively. We show that mutant and wild-type (WT) VP4 proteins are localized to cellular membranes after the 135S conformational transition. Both WT and viable 4028T mutant particles interact with lipid bilayers to form ion channels, whereas the entry-defective 4028T.G particles do not. In addition, the electrical properties of the channels induced by the mutant viruses are different from each other and from those of WT Mahoney and Sabin type 3 viruses. Finally, uncoating and/or cytoplasmic delivery of the viral genome is altered in the 4028T mutants: the 4028T.G lethal mutant does not release its genome into the cytoplasm, and genome delivery is slower during infection by mutant 4028T.V 135S particles than by mutant 4028T.S or WT 135S particles. The distinctive electrical characteristics of the different 4028T mutant channels indicate that VP4 sequences might form part of the channel structure. The different entry phenotypes of these VP4 mutants suggest that the ion channels may be related to VP4's role during genome uncoating and/or delivery.Poliovirus, a member of the Picornaviridae family, encapsidates its 7,400-nucleotide positive-sensed RNA genome within an icosahedrally symmetric protein shell that is formed by 60 copies of the four capsid proteins (VP1 to VP4). VP1, VP2, and VP3 form the surface of the virion, with VP1 located at each fivefold axis and VP2 and VP3 alternately positioned around each threefold axis. VP4 in its entirety as well as the amino termini of VP1, VP2, and VP3 are buried within the interior of the capsid, lying along the inner surface of the virion shell (12).Poliovirus entry into cells is initiated by binding to the poliovirus receptor (PVR) on the cell surface. PVR binding induces a conformational transition within the virus particle that leads to formation of altered particles (termed A particles) sedimenting at 135S (versus the 160S sedimentation value of the native particle) (references 8 and 23 and references therein). This conformational transition results in relocation of VP4 and the VP1 N termini from the particle interior to the virion exterior. The appearance of VP4 and VP1 domains on the particle surface is correlated with dramatic differences in the functional behavior of the native 160S and altered 135S particles. Functionally, these PVR-induced conformational rearrangements generate 135S particles that acquire the ability to bind to liposomes, to form ion channels in lipid bilayers, and ...

Cell death is a common outcome of virus infection. In some cases, cell death curbs virus replication. In others, cell death enhances virus dissemination and contributes to tissue injury, exacerbating viral disease. Three forms of cell death are observed following virus infection-apoptosis, necroptosis, and pyroptosis. In this review, I describe the core machinery needed for each of these forms of cell death. Using representative viruses, I highlight how distinct stages of virus replication initiate signaling pathways that elicit these forms of cell death. I also discuss viral strategies to overcome the deleterious effects of cell death on virus propagation and the consequences of cell death for host physiology.

No abstract